BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+0.63%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.27B
AUM Growth
+$1.27B
(-0.59%)
Cap. Flow
-$230K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
STAAR Surgical
STAA
|
$230K |
Sector Composition
| 1 | Healthcare | 52.32% |
| 2 | Consumer Staples | 29.37% |
| 3 | Industrials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $611M | 48.01% | 10,795,348 -4,062 | -0% | -$230K |
|
2
Monster Beverage
MNST
$60.9B
| $373M | 29.37% | 4,656,488 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $164M | 12.9% | 1,095,000 | – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $68.9M | 5.42% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $31.8M | 2.5% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $20.5M | 1.61% | 14,716,204 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $2.43M | 0.19% | 2,997,156 | – | – |
|